![]() |
市场调查报告书
商品编码
1846086
2024 年至 2031 年吹灌封技术市场(按产品类型、材料类型、最终用户产业和地区划分)Blow-Fill-Seal Technology Market by Product Type (Bottles, Vials, Ampoules, Pre-filled Syringes & Injectables), Material Type (Polypropylene, Polyethylene), End-User Industry (Pharmaceutical, Food & Beverages), & Region for 2024- 2031 |
||||||
製药业对无菌安全包装的需求日益增长,是吹灌封 (BFS) 技术市场的主要驱动力。该技术将吹瓶、填充和封口操作整合到一个自动化系统中,提高了生产效率,同时减少了污染问题,解决了製药和食品行业面临的重大药物输送和包装挑战。根据 Verified Market Research 分析师预测,到 2024 年,吹灌封技术市场规模预计将下降至约 603.5 亿美元,预测期内估值将达到 2,956.1 亿美元。
慢性病的增加以及随之而来的对注射药物的需求、对患者安全和依从性的日益关注是推动吹灌封 (BFS) 技术市场发展的关键因素,预计 2024 年至 2031 年的复合年增长率将达到 21.97%。
吹灌封技术市场定义/概述
吹-灌-封 (BFS) 技术是一种用于无菌液体产品包装的自动化生产工艺,可连续成型、填充和密封塑胶容器。此工艺主要包含三个步骤:将热塑性塑胶管吹製成所需的容器形状、将产品填充其中以及进行密封以保持无菌和产品完整性。由于 BFS 技术具有降低污染风险、降低生产成本和延长保质期等优势,因此在製药业中被广泛用于包装各种产品,包括注射、疫苗、眼药水和其他无菌液体製剂。
製药业是吹灌封 (BFS) 技术市场的主要驱动力。根据美国食品药物管理局 (FDA) 的报告,2023 年新药认证将年增 13%,其中许多新药将需要无菌包装解决方案。 BFS 技术非常适合满足这一日益增长的需求,因为它可以生产无菌的单剂量容器。
永续性正成为包装决策中的重要考量。根据《欧洲塑胶公约》,BFS 技术与标准包装方法相比,可节省高达 40% 的塑胶。这与欧盟在 2030 年实现所有塑胶包装可回收或重复使用的目标一致。
此外,食品和饮料行业也越来越多地使用BFS技术来包装单份产品。全球食品安全倡议(GFSI) 报告称,从2020年到2023年,包括BFS在内的无菌包装技术在食品生产中的使用将增加22%。这一趋势的驱动力在于人们对更长保质期和更高食品安全性的追求。
生物基预处理(BFS)设备和机械的高昂前期成本对新参与企业和中小企业采用该技术构成了重大障碍。生物基预处理系统非常复杂,需要大量的资本投入,这限制了市场扩张,尤其是在资金筹措困难的低度开发国家。
此外,BFS技术最适合包装液体和半液体物料,这限制了其在更大包装需求中的应用。这项限制可能会限制BFS系统在固态和粉末製剂常见的行业和应用中的使用,从而阻碍整体市场的扩张。
The growing need for sterile and safe packaging options in the pharmaceutical industry is the main driver of the blow-fill-seal (BFS) technology market. This technology combines the blowing, filling, and sealing operations into a single automated system, increasing production efficiency while reducing contamination concerns, thereby addressing significant difficulties in drug delivery and packaging for both the pharmaceutical and food industries. According to the analyst from Verified Market Research, the blow-fill-seal technology market is estimated to reach a valuation of USD 295.61 Billion over the forecast subjugating around USD 60.35 Billion valued in 2024.
The rising prevalence of chronic diseases and the resulting need for injectable drugs, combined with a growing emphasis on patient safety and compliance, are key factors propelling the blow-fill-seal (BFS) technology market forward. It enables the market to grow at a CAGR of 21.97% from 2024 to 2031.
Blow-Fill-Seal Technology Market: Definition/Overview
Blow-Fill-Seal (BFS) technology is an automated manufacturing technique for aseptic liquid product packaging that involves continuously forming, filling, and sealing plastic containers. This technology consists of three major steps: blowing a thermoplastic tube into the required container shape, filling it with the product, and hermetically sealing it to maintain sterility and product integrity. BFS technology is widely used in the pharmaceutical industry to package a variety of products, including injectable medications, vaccines, ophthalmic solutions, and other sterile liquid formulations, due to its benefits in reducing contamination risks, lowering production costs, and increasing shelf life.
The pharmaceutical industry is a key driver of the blow-fill-seal (BFS) technology market. According to an FDA report, new medicine approvals increased by 13% in 2023 compared to the previous year, with many requiring sterile packaging solutions. The BFS technology's capacity to manufacture sterile, single-dose containers makes it suitable for meeting this expanding need.
Sustainability is becoming an important consideration in packaging decisions. According to the European Plastics Pact, BFS technology can save up to 40% more plastic than standard packaging methods. This coincides with the European Union's goal of making all plastic packaging recyclable or reused by 2030.
Furthermore, the food and beverage industry is increasingly using BFS technology to package single-serve items. The Global Food Safety Initiative (GFSI) reported a 22% rise in the usage of aseptic packaging techniques, including BFS, in the food business between 2020 and 2023. This trend is driven by the desire for longer shelf life and higher food safety.
The high initial costs involved with BFS gear and equipment create a substantial barrier for new entrants and smaller businesses seeking to implement this technology. The complexity of BFS systems necessitates significant capital expenditure, limiting market expansion, particularly in underdeveloped countries with limited access to funding.
Furthermore, the BFS technology is best suited for packaging liquid and semi-liquid materials, which limits its application to larger packaging requirements. This constraint limits the use of BFS systems in industries or applications where solid or powdered formulations are more common, potentially impeding overall market expansion.
According to VMR analyst, the bottle segment is anticipated to dominate the segment within the blow-fill-seal technology market during the forecast period. BFS technology enables the production of bottles in a variety of sizes and forms, meeting the unique packaging needs of industries such as medicines, food, and cosmetics. This adaptability helps producers to address specific product requirements while also improving consumer convenience.
Bottles are commonly used to package liquid drugs such as eye drops, nasal sprays, and oral solutions. The growing need for sterile packaging solutions in the pharmaceutical industry is a major driver of the growth of the bottles segment in the BFS technology market.
Furthermore, ongoing research and development activities are aimed at increasing machine efficiency, optimizing packaging designs, and discovering novel materials that are compatible with BFS technology. These advances are projected to improve the capabilities and usage of BFS bottles, accelerating segment growth in the next years.
The pharmaceutical segment is estimated to hold the largest share of the blow-fill-seal technology market during the forecast period. The pharmaceutical industry is experiencing an increase in demand for sterile packaging solutions as injectable medications and biologics become more common. BFS technology provides an effective means for making containers that reduce contamination risks, ensure product safety, and comply with high regulatory criteria, resulting in its widespread application in this market.
The fast growth of biologics and injectable drugs is a major driver in the pharmaceutical BFS market. Because these treatments require particular packaging to retain their efficacy and sterility, BFS technology offers a suitable solution by combining the processes of container construction, filling, and sealing, catering precisely to the needs of these sensitive formulations.
Furthermore, patient safety and medication adherence are becoming increasingly important in the healthcare business. This approach is supported by BFS technology, which allows for the creation of single-dose containers that improve dosage accuracy and lower the risk of contamination, resulting in better patient outcomes and increased demand in the pharmaceutical market.
North America is estimated to exhibit substantial growth during the forecast period. From 2020 to 2023, the United States Food and Medicine Administration (FDA) reported a 15% rise in medicine recalls owing to packaging concerns. This has resulted in a wider use of BFS technology in North America, as it reduces the danger of contamination while improving product integrity. The FDA also reported that BFS-packaged products had 30% fewer recalls than standard packaging methods during the same period.
The North American biopharmaceutical market has been rapidly expanding. According to the Pharmaceutical Research and Manufacturers of America (PhRMA), the United States alone has over 800 biologics in development as of 2023, representing a 25% increase from 2020. These sensitive items require aseptic packing, which BFS technology excels at.
Furthermore, the North American healthcare system is moving toward unit-dose packaging to increase patient safety and prevent pharmaceutical mistakes. According to the American Society of Health-System Pharmacists (ASHP), the percentage of hospitals that use unit-dose systems has climbed from 68% in 2020 to 83% in 2023. BFS technology is suited for making such single-dose containers, which has fueled its development in the region.
The Asia Pacific is estimated to dominate the blow-fill-seal technology market during the forecast period. The Asia Pacific pharmaceutical market has been rapidly expanding. According to an International Trade Administration estimate, the pharmaceutical industry in Asia Pacific was valued at USD 365 Billion in 2022, with a compound annual growth rate (CAGR) of 8.4% through 2027. This increase is fueling demand for innovative packaging technologies such as Blow-Fill-Seal.
Many Asian countries are boosting healthcare spending and launching programs to improve healthcare infrastructure. The World Health Organization reported that healthcare spending in Southeast Asia climbed from 3.5% of GDP in 2010 to 4.9% in 2023. This increasing investment is accelerating the implementation of new medical technology, such as BFS for pharmaceutical packaging.
Furthermore, with increasing concerns about product safety and contamination, there is a greater demand for sterile packaging solutions. From 2020 to 2023, the China Food and Drug Administration reported a 30% growth in the deployment of aseptic packaging technologies, including BFS, in the pharmaceutical and healthcare sectors. This trend is especially prevalent in nations with substantial generic medicine manufacturing sectors, such as India and China.
The competitive landscape of the blow-fill-seal (BFS) technology market is characterized by fierce competition among multiple domestic and international competitors vying for market dominance in a constantly expanding sector. Companies are increasingly relying on strategic activities like mergers, acquisitions, and partnerships to improve their technology skills and broaden their product offerings.
Some of the prominent players operating in the blow-fill-seal technology market include:
Syntegon Technology GmbH
Bosch Packaging Technology GmbH
Buhl France SAS
IWK Verpackungstechnik GmbH
Marchesini Group S.p.A.
Romaco Holding GmbH
Nissei ASB Machine Co., Ltd.
Vetter Pharma International GmbH
Bausch + Strobel Maschinenbau GmbH
Optima Machinery GmbH
In December 2021, Woodstock received a US patent for their Cold BFS system. This technique regulates temperature to prevent heat damage, making it excellent for heat-sensitive pharmaceuticals.
In January 2021, Berry Global Healthcare introduced Cyrano, their lightest blow-fill seal closure. It aims to reduce plastic waste and offer a simple solution for all intravenous and infusion systems.
Blow-Fill-Seal Technology Market, by Category
Product Type:
Bottles
Vials
Ampoules
Pre-filled Syringes & Injectables
Material Type:
Polypropylene
Polyethylene
End-User Industry:
Pharmaceutical
Food & Beverages
Others
Region:
North America
Europe
Asia Pacific
Latin America
Middle East & Africa